NRIX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 6.20%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $160,364.65

Nurix Therapeutics Insider Trading History Chart

Nurix Therapeutics Share Price & Price History

^$12.13

▼ -0.39 (-3.12%)

As of 02/6/2023 01:00 AM ET

Days: 30 | 90 | 365

The #1 Energy Stock to Buy

From Wall Street Watch Dogs | Ad

The next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…

Get the Name & Ticker Here

Nurix Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/30/2023	Christine Ring	General Counsel	Sell	848	$11.78	$9,989.44	7,261
1/30/2023	Gwenn Hansen	Insider	Sell	1,412	$11.78	$16,633.36	23,009
1/30/2023	Houte Hans Van	CFO	Sell	924	$11.78	$10,884.72	76,765
1/30/2023	Stefani Wolff	COO	Sell	424	$11.78	$4,994.72	3,940
10/31/2022	Christine Ring	General Counsel	Sell	699	$12.88	$9,003.12	6,185
10/31/2022	Gwenn Hansen	Insider	Sell	1,165	$12.88	$15,005.20	21,214
10/31/2022	Houte Hans Van	CFO	Sell	739	$12.88	$9,518.32	74,803
10/31/2022	Stefani Wolff	COO	Sell	350	$12.88	$4,508.00	3,402
8/1/2022	Christine Ring	General Counsel	Sell	712	$15.67	$11,157.04	4,615
8/1/2022	Gwenn Hansen	Insider	Sell	1,186	$15.67	$18,584.62	19,172
8/1/2022	Houte Hans Van	CFO	Sell	752	$15.67	$11,783.84	72,656
8/1/2022	Stefani Wolff	COO	Sell	356	$15.67	$5,578.52	1,238
5/2/2022	Christine Ring	General Counsel	Sell	660	$11.75	$7,755.00	3,403
5/2/2022	Gwenn Hansen	Insider	Sell	1,098	$11.75	$12,901.50	17,151
5/2/2022	Houte Hans Van	CFO	Sell	697	$11.75	$8,189.75	2,189
5/2/2022	Stefani Wolff	COO	Sell	330	$11.75	$3,877.50	632
12/10/2021	Christine Ring	General Counsel	Sell	1,200	$29.04	$34,848.00
12/1/2021	Gwenn Hansen	Insider	Sell	400	$29.13	$11,652.00
11/1/2021	Gwenn Hansen	Insider	Sell	400	$33.24	$13,296.00
10/27/2021	Christine Ring	General Counsel	Sell	800	$35.25	$28,200.00
10/27/2021	Gwenn Hansen	Insider	Sell	400	$35.00	$14,000.00
10/11/2021	Christine Ring	General Counsel	Sell	1,200	$27.36	$32,832.00
10/1/2021	Gwenn Hansen	Insider	Sell	400	$29.92	$11,968.00
9/7/2021	Christine Ring	General Counsel	Sell	3,200	$35.25	$112,800.00
9/7/2021	Gwenn Hansen	Insider	Sell	1,600	$35.00	$56,000.00	15,797
8/10/2021	Christine Ring	General Counsel	Sell	1,200	$29.87	$35,844.00	2,005
8/10/2021	Pierre Beaurang	Insider	Sell	7,500	$29.86	$223,950.00
8/2/2021	Gwenn Hansen	Insider	Sell	400	$31.21	$12,484.00	14,204
7/20/2021	Christine Ring	General Counsel	Sell	1,200	$27.00	$32,400.00
7/12/2021	Pierre Beaurang	Insider	Sell	7,500	$23.92	$179,400.00	11,830
6/10/2021	Christine Ring	General Counsel	Sell	1,200	$29.40	$35,280.00	2,005
6/10/2021	Pierre Beaurang	Insider	Sell	7,500	$29.37	$220,275.00	11,830
6/1/2021	Gwenn Hansen	Insider	Sell	400	$27.74	$11,096.00	14,204
5/10/2021	Christine Ring	General Counsel	Sell	1,200	$27.00	$32,400.00	2,005
4/12/2021	Christine Ring	General Counsel	Sell	1,200	$27.20	$32,640.00	2,005
4/12/2021	Pierre Beaurang	Insider	Sell	7,500	$27.28	$204,600.00
4/5/2021	Gwenn Hansen	Insider	Sell	400	$35.00	$14,000.00	14,204
4/1/2021	Gwenn Hansen	Insider	Sell	400	$31.55	$12,620.00	14,204
3/16/2021	Gwenn Hansen	Insider	Sell	800	$45.00	$36,000.00	14,604
3/10/2021	Christine Ring	General Counsel	Sell	2,000	$41.27	$82,540.00
3/1/2021	Gwenn Hansen	Insider	Sell	800	$35.95	$28,760.00
2/22/2021	Houte Hans Van	CFO	Sell	5,330	$39.93	$212,826.90	1,417

A gold storm is coming…

From Wall Street Watch Dogs | Ad

“We are in the early stages of a mania – the calm before the storm.”...

[Full Story]

SEC Filings (Institutional Ownership Changes) for Nurix Therapeutics (NASDAQ:NRIX)

91.33% of Nurix Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Nurix Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/6/2023	Los Angeles Capital Management LLC	106,479	$1.17M	0.0%	+57.4%	0.226%
2/6/2023	Jackson Creek Investment Advisors LLC	49,662	$0.55M	0.2%	-9.7%	0.105%
2/2/2023	AtonRa Partners	36,928	$0.41M	0.5%	-21.3%	0.078%
2/1/2023	Zurcher Kantonalbank Zurich Cantonalbank	6,312	$69K	0.0%	+23.3%	0.013%
1/24/2023	ARK Investment Management LLC	1,988,254	$21.83M	0.2%	+54.5%	4.217%
12/8/2022	Bank of New York Mellon Corp	158,760	$2.07M	0.0%	+17.0%	0.337%
11/16/2022	Balyasny Asset Management LLC	15,930	$0.21M	0.0%	N/A	0.034%
11/16/2022	BNP Paribas Arbitrage SNC	76,415	$1M	0.0%	N/A	0.162%
11/15/2022	Nomura Holdings Inc.	238,204	$3.10M	0.0%	-22.2%	0.505%
11/15/2022	Alliancebernstein L.P.	82,900	$1.08M	0.0%	+13.2%	0.176%
11/15/2022	State Street Corp	2,312,224	$30.13M	0.0%	+9.2%	4.904%
11/15/2022	Public Employees Retirement System of Ohio	74,739	$0.97M	0.0%	+27.4%	0.159%
11/15/2022	Jacobs Levy Equity Management Inc.	12,851	$0.17M	0.0%	N/A	0.027%
11/15/2022	Algert Global LLC	22,594	$0.29M	0.0%	+50.8%	0.048%
11/15/2022	Trexquant Investment LP	24,986	$0.33M	0.0%	+141.4%	0.053%
11/15/2022	UBS Asset Management Americas Inc.	230,592	$3.01M	0.0%	-5.6%	0.489%
11/15/2022	Vanguard Group Inc.	2,160,866	$28.16M	0.0%	+2.3%	4.583%
11/15/2022	Price T Rowe Associates Inc. MD	3,606,352	$46.99M	0.0%	-22.0%	7.649%
11/15/2022	Ensign Peak Advisors Inc	86,967	$1.13M	0.0%	+2.6%	0.184%
11/15/2022	Bank of New York Mellon Corp	158,760	$2.07M	0.0%	+17.0%	0.337%
11/15/2022	BlackRock Inc.	3,723,090	$48.51M	0.0%	+11.0%	7.896%
11/14/2022	Tudor Investment Corp Et Al	22,197	$0.29M	0.0%	+9.1%	0.047%
11/14/2022	Cubist Systematic Strategies LLC	131,919	$1.72M	0.0%	+92.1%	0.280%
11/14/2022	Fiduciary Trust Co.	14,074	$0.18M	0.0%	+31.3%	0.030%
11/14/2022	Renaissance Technologies LLC	73,300	$0.96M	0.0%	-38.1%	0.155%
11/14/2022	Blackstone Inc.	27,119	$0.35M	0.0%	+60.8%	0.058%
11/14/2022	Nuveen Asset Management LLC	552,656	$7.20M	0.0%	+70.3%	1.172%
11/14/2022	Hsbc Holdings PLC	12,174	$0.16M	0.0%	N/A	0.026%
11/14/2022	Pictet Asset Management SA	1,076,349	$14.03M	0.0%	-24.8%	2.283%
11/10/2022	Credit Suisse AG	28,850	$0.38M	0.0%	+84.7%	0.061%
11/10/2022	ExodusPoint Capital Management LP	25,954	$0.34M	0.0%	N/A	0.055%
11/10/2022	Dimensional Fund Advisors LP	334,725	$4.36M	0.0%	+63.8%	0.710%
11/10/2022	Tower Research Capital LLC TRC	10,035	$0.13M	0.0%	+121.6%	0.021%
11/10/2022	UBS Group AG	41,791	$0.55M	0.0%	-29.6%	0.089%
11/9/2022	Bessemer Group Inc.	357,287	$4.66M	0.0%	+17.1%	0.758%
11/7/2022	Quantbot Technologies LP	8,600	$0.11M	0.0%	+760.0%	0.018%
11/7/2022	Jump Financial LLC	43,800	$0.57M	0.0%	+15.3%	0.093%
11/3/2022	Teacher Retirement System of Texas	10,989	$0.14M	0.0%	N/A	0.023%
11/3/2022	Barclays PLC	84,491	$1.10M	0.0%	+2,993.8%	0.179%
11/2/2022	Los Angeles Capital Management LLC	67,655	$0.88M	0.0%	+410.0%	0.143%
11/2/2022	Victory Capital Management Inc.	11,305	$0.15M	0.0%	-9.5%	0.024%
11/1/2022	Great West Life Assurance Co. Can	1,891	$25K	0.0%	N/A	0.004%
10/31/2022	SG Americas Securities LLC	23,873	$0.31M	0.0%	-30.2%	0.051%
10/25/2022	Denali Advisors LLC	3,600	$47K	0.0%	N/A	0.008%
10/25/2022	Raymond James & Associates	51,079	$0.67M	0.0%	+23.7%	0.108%
10/17/2022	ARK Investment Management LLC	1,286,522	$16.76M	0.1%	+65.2%	2.729%
8/22/2022	Legal & General Group Plc	12,173	$0.15M	0.0%	+35.9%	0.026%
8/18/2022	Goldman Sachs Group Inc.	331,843	$4.20M	0.0%	+5.1%	0.705%
8/17/2022	Nomura Holdings Inc.	306,001	$4.06M	0.0%	+0.2%	0.650%
8/16/2022	Thrivent Financial for Lutherans	15,177	$0.19M	0.0%	N/A	0.032%
8/16/2022	Price T Rowe Associates Inc. MD	4,620,823	$58.55M	0.0%	-3.9%	9.823%
8/16/2022	DAFNA Capital Management LLC	566,695	$7.18M	2.0%	+4.3%	1.205%
8/15/2022	State Street Corp	2,116,771	$26.82M	0.0%	-8.1%	4.500%
8/15/2022	Cubist Systematic Strategies LLC	68,684	$0.87M	0.0%	+15.3%	0.146%
8/15/2022	Bain Capital Life Sciences Investors LLC	1,822,883	$23.10M	2.7%	+41.9%	3.875%
8/15/2022	Millennium Management LLC	811,928	$10.29M	0.0%	+121.7%	1.726%
8/15/2022	Nomura Holdings Inc.	306,001	$4.06M	0.0%	+0.2%	0.650%
8/15/2022	UBS Asset Management Americas Inc.	244,305	$3.10M	0.0%	-3.5%	0.519%
8/13/2022	Renaissance Technologies LLC	118,400	$1.50M	0.0%	+55.4%	0.252%
8/13/2022	American International Group Inc.	20,752	$0.26M	0.0%	+33.5%	0.044%
8/12/2022	Northern Trust Corp	388,194	$4.92M	0.0%	+27.5%	0.825%
8/12/2022	Virtus ETF Advisers LLC	10,735	$0.14M	0.1%	+89.1%	0.023%
8/12/2022	Credit Suisse AG	15,619	$0.20M	0.0%	+7.9%	0.033%
8/12/2022	ClariVest Asset Management LLC	49,700	$0.63M	0.0%	N/A	0.106%
8/12/2022	Rafferty Asset Management LLC	71,049	$0.90M	0.0%	-51.4%	0.151%
8/12/2022	FMR LLC	1,790,655	$22.69M	0.0%	+59.6%	3.807%
8/12/2022	Rhumbline Advisers	63,039	$0.80M	0.0%	+88.1%	0.134%
8/11/2022	Trexquant Investment LP	10,350	$0.13M	0.0%	-76.7%	0.022%
8/11/2022	UBS Group AG	59,341	$0.75M	0.0%	-60.1%	0.126%
8/11/2022	Bank of Montreal Can	24,104	$0.29M	0.0%	N/A	0.051%
8/11/2022	JPMorgan Chase & Co.	129,525	$1.64M	0.0%	+7.5%	0.275%
8/9/2022	Swiss National Bank	79,000	$1M	0.0%	+66.3%	0.168%
8/9/2022	Pictet Asset Management SA	1,430,365	$18.12M	0.0%	-0.6%	3.041%
8/5/2022	State Board of Administration of Florida Retirement System	22,691	$0.29M	0.0%	N/A	0.048%
8/4/2022	TD Asset Management Inc.	43,259	$0.55M	0.0%	-31.5%	0.092%
8/4/2022	Jackson Creek Investment Advisors LLC	55,057	$0.88M	0.4%	N/A	0.117%
8/3/2022	Nisa Investment Advisors LLC	2,200	$28K	0.0%	-90.4%	0.005%
8/3/2022	Candriam S.C.A.	839,375	$10.63M	0.1%	+9.7%	1.784%
7/29/2022	SG Americas Securities LLC	34,221	$0.43M	0.0%	N/A	0.073%
7/26/2022	Mirae Asset Global Investments Co. Ltd.	10,098	$0.13M	0.0%	N/A	0.021%
7/11/2022	ARK Investment Management LLC	778,725	$7.86M	0.0%	+98.7%	1.732%
6/30/2022	Amalgamated Bank	4,981	$70K	0.0%	N/A	0.011%
6/7/2022	Bank of America Corp DE	52,550	$0.74M	0.0%	-40.6%	0.117%
5/20/2022	The Manufacturers Life Insurance Company	66,700	$0.94M	0.0%	+307.2%	0.148%
5/18/2022	Nomura Holdings Inc.	305,340	$4.27M	0.0%	+72.8%	0.679%
5/17/2022	Alyeska Investment Group L.P.	120,750	$1.69M	0.0%	+5.0%	0.269%
5/17/2022	Quantbot Technologies LP	5,600	$78K	0.0%	+211.1%	0.012%
5/17/2022	Royal Bank of Canada	2,027	$28K	0.0%	-71.4%	0.005%
5/17/2022	Ensign Peak Advisors Inc	84,797	$1.19M	0.0%	+1,634.1%	0.189%
5/16/2022	California State Teachers Retirement System	30,372	$0.43M	0.0%	-10.1%	0.068%
5/16/2022	Goldman Sachs Group Inc.	315,666	$4.42M	0.0%	+2.3%	0.702%
5/16/2022	Blackstone Inc.	16,862	$0.24M	0.0%	+18.8%	0.038%
5/16/2022	Woodline Partners LP	219,281	$3.07M	0.0%	-63.0%	0.488%
5/16/2022	Wellington Management Group LLP	842,373	$11.80M	0.0%	-27.5%	1.874%
5/16/2022	State Street Corp	2,302,544	$32.26M	0.0%	+47.8%	5.122%
5/16/2022	Graham Capital Management L.P.	12,350	$0.17M	0.0%	N/A	0.027%
5/16/2022	UBS Group AG	148,704	$2.08M	0.0%	+49.7%	0.331%
5/16/2022	Hsbc Holdings PLC	11,615	$0.17M	0.0%	N/A	0.026%
5/13/2022	Renaissance Technologies LLC	76,200	$1.07M	0.0%	N/A	0.170%
5/13/2022	Northern Trust Corp	304,537	$4.27M	0.0%	-3.6%	0.678%

Data available starting January 2016

Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies; NX-5948, an orally bioavailable BTK degrader for the treatment of relapsed or refractory B-cell malignancies and autoimmune diseases; and NX-1607, an orally available Casitas B-lineage lymphoma proto-oncogene-B (CBL-B) inhibitor for immuno-oncology indications. It also develops NX-0255, a CBL-B inhibitor for ex vivo use to enhance adoptive T-cell therapy; and DeTIL-0255 that is in the Phase 1 clinical trial for the treatment of gynecologic cancers, including ovarian, endometrial, and cervical cancer. The company has a strategic collaboration agreement with Gilead Sciences, Inc. for cancer and other challenging diseases patients; and Sanofi S.A. The company was formerly known as Nurix Inc. and changed its name to Nurix Therapeutics, Inc. in October 2018. The company was incorporated in 2009 and is headquartered in San Francisco, California.

Today's Range

Now: $12.13

$11.88

$12.57

50 Day Range

MA: $11.72

$9.86

$13.26

52 Week Range

Now: $12.13

$7.52

$20.20

Volume

186,629 shs

Average Volume

283,065 shs

Market Capitalization

$571.93 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.65

Who are the company insiders with the largest holdings of Nurix Therapeutics?: Nurix Therapeutics' top insider investors include:
Houte Hans Van (CFO)
Gwenn Hansen (Insider)
Pierre Beaurang (Insider)
Christine Ring (General Counsel)
Stefani Wolff (COO)
Learn More about top insider investors at Nurix Therapeutics.
Who are the major institutional investors of Nurix Therapeutics?: Nurix Therapeutics' top institutional investors include:
ARK Investment Management LLC — 4.22%
Los Angeles Capital Management LLC — 0.23%
Jackson Creek Investment Advisors LLC — 0.11%
AtonRa Partners — 0.08%
Zurcher Kantonalbank Zurich Cantonalbank — 0.01%
Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of Nurix Therapeutics stock.
Which institutional investors are selling Nurix Therapeutics stock?: During the last quarter, NRIX stock was sold by these institutional investors:
AtonRa Partners
Jackson Creek Investment Advisors LLC
Within the last year, company insiders that have sold Nurix Therapeutics company stock include:
Houte Hans Van (CFO)
Gwenn Hansen (Insider)
Pierre Beaurang (Insider)
Christine Ring (General Counsel)
Learn More investors selling Nurix Therapeutics stock.
Which institutional investors are buying Nurix Therapeutics stock?: Within the previous quarter, NRIX stock was purchased by institutional investors including:
ARK Investment Management LLC
Los Angeles Capital Management LLC
Zurcher Kantonalbank Zurich Cantonalbank